Global Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1234

Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.
In 2018, the global Lung Cancer Liquid Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lung Cancer Liquid Biopsy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer Liquid Biopsy development in United States, Europe and China.

The key players covered in this study
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
Qiagen
Accuragen
Agena Bioscience
Bard1
Bgi

Market segment by Type, the product can be split into
CTCs
CtDNA
Exosomes And RNA
Others

Market segment by Application, split into
Clinics
Hospitals
Physicians' Office Laboratories

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lung Cancer Liquid Biopsy status, future forecast, growth opportunity, key market and key players.
To present the Lung Cancer Liquid Biopsy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lung Cancer Liquid Biopsy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type (2014-2025)
1.4.2 CTCs
1.4.3 CtDNA
1.4.4 Exosomes And RNA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Lung Cancer Liquid Biopsy Market Share by Application (2014-2025)
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Physicians' Office Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lung Cancer Liquid Biopsy Market Size
2.2 Lung Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions (2014-2025)
2.2.2 Lung Cancer Liquid Biopsy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lung Cancer Liquid Biopsy Market Size by Manufacturers
3.1.1 Global Lung Cancer Liquid Biopsy Revenue by Manufacturers (2014-2019)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Liquid Biopsy Key Players Head office and Area Served
3.3 Key Players Lung Cancer Liquid Biopsy Product/Solution/Service
3.4 Date of Enter into Lung Cancer Liquid Biopsy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Liquid Biopsy Market Size by Type (2014-2019)
4.2 Global Lung Cancer Liquid Biopsy Market Size by Application (2014-2019)

5 United States
5.1 United States Lung Cancer Liquid Biopsy Market Size (2014-2019)
5.2 Lung Cancer Liquid Biopsy Key Players in United States
5.3 United States Lung Cancer Liquid Biopsy Market Size by Type
5.4 United States Lung Cancer Liquid Biopsy Market Size by Application

6 Europe
6.1 Europe Lung Cancer Liquid Biopsy Market Size (2014-2019)
6.2 Lung Cancer Liquid Biopsy Key Players in Europe
6.3 Europe Lung Cancer Liquid Biopsy Market Size by Type
6.4 Europe Lung Cancer Liquid Biopsy Market Size by Application

7 China
7.1 China Lung Cancer Liquid Biopsy Market Size (2014-2019)
7.2 Lung Cancer Liquid Biopsy Key Players in China
7.3 China Lung Cancer Liquid Biopsy Market Size by Type
7.4 China Lung Cancer Liquid Biopsy Market Size by Application

8 Japan
8.1 Japan Lung Cancer Liquid Biopsy Market Size (2014-2019)
8.2 Lung Cancer Liquid Biopsy Key Players in Japan
8.3 Japan Lung Cancer Liquid Biopsy Market Size by Type
8.4 Japan Lung Cancer Liquid Biopsy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lung Cancer Liquid Biopsy Market Size (2014-2019)
9.2 Lung Cancer Liquid Biopsy Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type
9.4 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application

10 India
10.1 India Lung Cancer Liquid Biopsy Market Size (2014-2019)
10.2 Lung Cancer Liquid Biopsy Key Players in India
10.3 India Lung Cancer Liquid Biopsy Market Size by Type
10.4 India Lung Cancer Liquid Biopsy Market Size by Application

11 Central & South America
11.1 Central & South America Lung Cancer Liquid Biopsy Market Size (2014-2019)
11.2 Lung Cancer Liquid Biopsy Key Players in Central & South America
11.3 Central & South America Lung Cancer Liquid Biopsy Market Size by Type
11.4 Central & South America Lung Cancer Liquid Biopsy Market Size by Application

12 International Players Profiles
12.1 Biocept
12.1.1 Biocept Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Liquid Biopsy Introduction
12.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.1.5 Biocept Recent Development
12.2 Exosome Diagnostics
12.2.1 Exosome Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Liquid Biopsy Introduction
12.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.2.5 Exosome Diagnostics Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Liquid Biopsy Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 Qiagen
12.4.1 Qiagen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Liquid Biopsy Introduction
12.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.4.5 Qiagen Recent Development
12.5 Accuragen
12.5.1 Accuragen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Liquid Biopsy Introduction
12.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.5.5 Accuragen Recent Development
12.6 Agena Bioscience
12.6.1 Agena Bioscience Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Liquid Biopsy Introduction
12.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.6.5 Agena Bioscience Recent Development
12.7 Bard1
12.7.1 Bard1 Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Liquid Biopsy Introduction
12.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.7.5 Bard1 Recent Development
12.8 Bgi
12.8.1 Bgi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lung Cancer Liquid Biopsy Introduction
12.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2014-2019)
12.8.5 Bgi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details